ArticleFrontiers in oncology2025

Correction: TPL inhibits the invasion and migration of drug-resistant ovarian cancer by targeting the PI3K/AKT/NF-κB-signaling pathway to inhibit the polarization of M2 TAMs.

Fuyin Le et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.